FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Panel to Review Entasis Therapeutics NDA

Federal Register notice: FDA announces a 4/17 Antimicrobial Drugs Advisory Committee meeting to discuss an Entasis Therapeutics NDA for sulbactam-durl...

latest-news-card-1
Human Drugs

GAO Report Hits FDA on Advanced Manufacturing Tracking

A new Government Accountability Office report recommends that FDA better track the extent of its efforts to encourage drug manufacturers to adopt adva...

latest-news-card-1

FDA Outlines Disposition of Covid-19 Guidances

FDA publishes a Federal Register notice outlining the status of the many guidance documents that were issued to address the Covid-19 public health eme...

latest-news-card-1
Human Drugs

FDA Divides into Two its Guide on Face Masks

FDA splits into two its guidance entitled Enforcement Policy for Face Masks, Barrier Face Coverings, Face Shields, Surgical Masks, and Respirators Dur...

latest-news-card-1
Human Drugs

Pfizer NDA for Migraine Nasal Spray OKd

FDA approves a Pfizer NDA for Zavzpret (zavegepant), the first calcitonin gene-related peptide receptor antagonist nasal spray for treating adults wit...

latest-news-card-1
Medical Devices

18 Senators Want End to Accelerated Approval Pricing Model

A letter from 18 Republican senators urges HHS to abandon a Medicare pricing model that aims to balance incentives for developing novel treatments und...

latest-news-card-1
Medical Devices

Baxter Device Correction for Life2000 Ventilator

Baxter International issues an urgent medical device correction for its Life2000 Ventilation System due to the potential for patient oxygen desaturati...

latest-news-card-1
Biologics

FDA Approves Coherus Pegfilgrastim Autoinjector

FDA approves a Coherus BioSciences BLA for single-dose, prefilled autoinjector presentation of its Udenyca (pegfilgrastim-cbqv), a biosimilar of Amge...

latest-news-card-1
Human Drugs

FDA, EMA Parallel Scientific Advice is Effective: Study

FDA and European Medicines Agency staff describe the benefits seen in their joint Parallel Scientific Advice program.

latest-news-card-1
Human Drugs

Lilly Drops Solanezumab on Negative Results

Lilly says it is terminating the clinical development of solanezumab for preclinical Alzheimers disease after it failed to meet the primary or seconda...